skip to main content
Language:
Results 1 2 3 4 5 next page
Show only
Refined by: collection: Science Direct remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study
Material Type:
Article 		Add to e-Shelf

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study

Rosiñol, Laura ; Oriol, Albert ; Teruel, Ana Isabel ; Hernández, Dolores ; López-Jiménez, Javier ; de la Rubia, Javier ; Granell, Miquel ; Besalduch, Joan ; Palomera, Luis ; González, Yolanda ; Etxebeste, Mª Asunción ; Díaz-Mediavilla, Joaquín ; Hernández, Miguel T. ; de Arriba, Felipe ; Gutiérrez, Norma C. ; Martín-Ramos, Mª Luisa ; Cibeira, Mª Teresa ; Mateos, Mª Victoria ; Martínez, Joaquín ; Alegre, Adrián ; Lahuerta, Juan José ; San Miguel, Jesús ; Bladé, Joan

Blood, 2012-08, Vol.120 (8), p.1589-1596 [Peer Reviewed Journal]

Washington, DC: Elsevier Inc

Full text available

Citations Cited by
2
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
Material Type:
Article 		Add to e-Shelf

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

du Bois, Andreas, Prof ; Kristensen, Gunnar, Prof ; Ray-Coquard, Isabelle, Prof ; Reuss, Alexander, MSc ; Pignata, Sandro, MD ; Colombo, Nicoletta, Prof ; Denison, Ursula, MD ; Vergote, Ignace, Prof ; del Campo, Jose M, MD ; Ottevanger, Petronella, PhD ; Heubner, Martin, MD ; Minarik, Thomas, PhD ; Sevin, Emmanuel, MD ; de Gregorio, Nikolaus, MD ; Bidziński, Mariusz, Prof ; Pfisterer, Jacobus, Prof ; Malander, Susanne, MD ; Hilpert, Felix, Prof ; Mirza, Mansoor R, MD ; Scambia, Giovanni, Prof ; Meier, Werner, Prof ; Nicoletto, Maria O, MD ; Bjørge, Line, Prof ; Lortholary, Alain, MD ; Sailer, Martin Oliver, PhD ; Merger, Michael, MD ; Harter, Philipp, MD

The lancet oncology, 2016, Vol.17 (1), p.78-89 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available

Citations Cited by
3
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma
A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma
Material Type:
Article 		Add to e-Shelf

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Amengual, Jennifer E. ; Lichtenstein, Renee ; Lue, Jennifer ; Sawas, Ahmed ; Deng, Changchun ; Lichtenstein, Emily ; Khan, Karen ; Atkins, Laine ; Rada, Aishling ; Kim, Hye A. ; Chiuzan, Codruta ; Kalac, Matko ; Marchi, Enrica ; Falchi, Lorenzo ; Francescone, Mark A. ; Schwartz, Lawrence ; Cremers, Serge ; O'Connor, Owen A.

Blood, 2018-01, Vol.131 (4), p.397-407 [Peer Reviewed Journal]

United States: Elsevier Inc

Full text available

Citations Cited by
4
DNA binders in clinical trials and chemotherapy
DNA binders in clinical trials and chemotherapy
Material Type:
Article 		Add to e-Shelf

DNA binders in clinical trials and chemotherapy

Ali, Asfa ; Bhattacharya, Santanu

Bioorganic & medicinal chemistry, 2014-08, Vol.22 (16), p.4506-4521 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available

Citations Cited by
5
Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer
Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer
Material Type:
Article 		Add to e-Shelf

Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer

Greish, Khaled ; Mathur, Aanchal ; Al Zahrani, Reem ; Elkaissi, Sara ; Al Jishi, Muna ; Nazzal, Osama ; Taha, Safa ; Pittalà, Valeria ; Taurin, Sebastien

Journal of controlled release, 2018-12, Vol.291, p.184-195 [Peer Reviewed Journal]

Netherlands: Elsevier B.V

Full text available

Citations Cited by
6
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Material Type:
Article 		Add to e-Shelf

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Mittendorf, Elizabeth A ; Zhang, Hong ; Barrios, Carlos H ; Saji, Shigehira ; Jung, Kyung Hae ; Hegg, Roberto ; Koehler, Andreas ; Sohn, Joohyuk ; Iwata, Hiroji ; Telli, Melinda L ; Ferrario, Cristiano ; Punie, Kevin ; Penault-Llorca, Frédérique ; Patel, Shilpen ; Duc, Anh Nguyen ; Liste-Hermoso, Mario ; Maiya, Vidya ; Molinero, Luciana ; Chui, Stephen Y ; Harbeck, Nadia

The Lancet (British edition), 2020-10, Vol.396 (10257), p.1090-1100 [Peer Reviewed Journal]

England: Elsevier Ltd

Full text available

Citations Cited by
7
A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance
A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance
Material Type:
Article 		Add to e-Shelf

A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance

Xiao, Haihua ; Song, Haiqin ; Yang, Qiang ; Cai, Haidong ; Qi, Ruogu ; Yan, Lesan ; Liu, Shi ; Zheng, Yonghui ; Huang, Yubin ; Liu, Tongjun ; Jing, Xiabin

Biomaterials, 2012-09, Vol.33 (27), p.6507-6519 [Peer Reviewed Journal]

Netherlands: Elsevier Ltd

Full text available

Citations Cited by
8
Redox and pH-responsive gold nanoparticles as a new platform for simultaneous triple anti-cancer drugs targeting
Redox and pH-responsive gold nanoparticles as a new platform for simultaneous triple anti-cancer drugs targeting
Material Type:
Article 		Add to e-Shelf

Redox and pH-responsive gold nanoparticles as a new platform for simultaneous triple anti-cancer drugs targeting

Ghorbani, Marjan ; Hamishehkar, Hamed

International journal of pharmaceutics, 2017-03, Vol.520 (1-2), p.126-138 [Peer Reviewed Journal]

Netherlands: Elsevier B.V

Full text available

Citations Cited by
9
Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel
Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel
Material Type:
Article 		Add to e-Shelf

Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel

Wang, Baohua ; Hu, Wenxia ; Yan, Hongjiang ; Chen, Ge ; Zhang, Yaozhong ; Mao, Junjie ; Wang, Lei

Biomedicine & pharmacotherapy, 2021-04, Vol.136, p.111249, Article 111249 [Peer Reviewed Journal]

France: Elsevier Masson SAS

Full text available

Citations Cited by
10
The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer
The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer
Material Type:
Article 		Add to e-Shelf

The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer

Blackwell, Kimberly ; Gligorov, Joseph ; Jacobs, Ira ; Twelves, Chris

Clinical breast cancer, 2018-04, Vol.18 (2), p.95-113 [Peer Reviewed Journal]

United States: Elsevier Inc

Full text available

Citations Cited by
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (34,353)

Refine My Results

Resource Type 

  1. Articles  (35,412)
  2. Conference Proceedings  (25)
  3. magazinearticle  (14)
  4. Book Chapters  (5)
  5. More options open sub menu

Creation Date 

From To
Refine
  1. Before1981  (14)
  2. 1981To1990  (1,999)
  3. 1991To2000  (5,417)
  4. 2001To2011  (13,128)
  5. After 2011  (14,898)
  6. More options open sub menu

Language 

  1. English  (34,514)
  2. Japanese  (4,352)
  3. French  (812)
  4. Spanish  (218)
  5. Portuguese  (49)
  6. Russian  (41)
  7. Norwegian  (8)
  8. German  (1)
  9. Lithuanian  (1)
  10. More options open sub menu

  • Implemented by: ABCD-USP USP   Social Network Logos: Freepik

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far